Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial Spondyloarthritis

RAFAELA ORTEGA CASTRO2026-01-292026-01-29202210.3389/fimmu.2022.8941712-s2.0-85134665636https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/35066ImmunologyImmunology and AllergyIrisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial Spondyloarthritisresearch article